Sinapultide

Therapeutic

Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.

Structural features

SMILES

CC(C)C[C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)O)NC(=O)[C@@H](CCCCN)N

Sequence

KLLLLKLLLLKLLLLKLLLLK

Molar mass

2469.45 g/mol

Constitutional members:

21

Natural amino acids

0

D-Amino acids

0

N-terminus

H

C-terminus

COOH

Cyclic

no

Members/cycle

N.A.

Bond to form cycle

N.A.

Lipidation

no

Glycosylation

no

Route of administration

IT

Terminal half-life

-

Protein binding

-

Absorption and Bioavailability

-

References